Shi-Bing Su

4.1k total citations
125 papers, 2.9k citations indexed

About

Shi-Bing Su is a scholar working on Molecular Biology, Epidemiology and Complementary and alternative medicine. According to data from OpenAlex, Shi-Bing Su has authored 125 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 41 papers in Epidemiology and 25 papers in Complementary and alternative medicine. Recurrent topics in Shi-Bing Su's work include Liver Disease Diagnosis and Treatment (32 papers), Traditional Chinese Medicine Studies (22 papers) and Pancreatitis Pathology and Treatment (17 papers). Shi-Bing Su is often cited by papers focused on Liver Disease Diagnosis and Treatment (32 papers), Traditional Chinese Medicine Studies (22 papers) and Pancreatitis Pathology and Treatment (17 papers). Shi-Bing Su collaborates with scholars based in China, Japan and United States. Shi-Bing Su's co-authors include Qilong Chen, Yi-Yu Lu, Yoshiharu Motoo, Norio Sawabu, Qianmei Zhou, Min-Jue Xie, Hui Zhang, Qing‐Ya Li, Yang Sun and Feifei Cai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Shi-Bing Su

121 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shi-Bing Su China 30 1.3k 563 540 538 428 125 2.9k
Xiaojiaoyang Li China 33 1.6k 1.2× 662 1.2× 525 1.0× 1.1k 2.0× 436 1.0× 98 3.4k
Xiaoying Wang China 26 1.1k 0.9× 527 0.9× 675 1.3× 343 0.6× 454 1.1× 98 2.8k
Ji‐Xing Nan China 37 1.5k 1.2× 830 1.5× 244 0.5× 901 1.7× 419 1.0× 122 3.4k
Shizhang Wei China 29 894 0.7× 667 1.2× 271 0.5× 429 0.8× 349 0.8× 87 2.1k
Feifei Guo China 22 1.5k 1.2× 365 0.6× 300 0.6× 423 0.8× 285 0.7× 95 2.7k
Guang Liang China 40 2.3k 1.8× 301 0.5× 428 0.8× 621 1.2× 206 0.5× 129 4.7k
Hui‐Ling Chiou Taiwan 36 1.9k 1.4× 274 0.5× 598 1.1× 545 1.0× 188 0.4× 94 3.8k
Chenghai Liu China 29 931 0.7× 694 1.2× 262 0.5× 958 1.8× 381 0.9× 154 2.8k
Ming Niu China 29 1.2k 0.9× 887 1.6× 326 0.6× 393 0.7× 289 0.7× 134 2.5k
Runping Liu China 33 1.7k 1.3× 540 1.0× 623 1.2× 1.2k 2.3× 155 0.4× 99 3.5k

Countries citing papers authored by Shi-Bing Su

Since Specialization
Citations

This map shows the geographic impact of Shi-Bing Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi-Bing Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi-Bing Su more than expected).

Fields of papers citing papers by Shi-Bing Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi-Bing Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi-Bing Su. The network helps show where Shi-Bing Su may publish in the future.

Co-authorship network of co-authors of Shi-Bing Su

This figure shows the co-authorship network connecting the top 25 collaborators of Shi-Bing Su. A scholar is included among the top collaborators of Shi-Bing Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi-Bing Su. Shi-Bing Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Jingru, Zheng Wang, Dong Xie, et al.. (2024). Integrated metabolomics and network pharmacology to explore the clinical efficacy and mechanism of Yinchenhao decoction combined with nucleoside analogues on chronic hepatitis B. Journal of Pharmaceutical and Biomedical Analysis. 253. 116513–116513. 2 indexed citations
2.
Su, Shi-Bing, et al.. (2023). Mechanisms of Ganweikang Tablets against Chronic Hepatitis B: A Comprehensive Study of Network Analysis, Molecular Docking, and Chemical Profiling. BioMed Research International. 2023(1). 8782892–8782892. 5 indexed citations
3.
Zhao, Yu, et al.. (2021). Serum Cytokine Analysis Reveals Predictors of Progression from Chronic Hepatitis B to Liver Cirrhosis. Folia Biologica. 67(1). 28–36. 4 indexed citations
4.
L, Li, Liu L, Li X, et al.. (2020). Long Noncoding RNA SNHG7 Accelerates Proliferation, Migration and Invasion of Non-Small Cell Lung Cancer Cells by Suppressing miR-181a-5p Through AKT/mTOR Signaling Pathway. SHILAP Revista de lepidopterología. 3 indexed citations
5.
Li, Guangyao, Yuan Zhou, Daniel Sze, et al.. (2019). Active Ingredients and Action Mechanisms of Yi Guan Jian Decoction in Chronic Hepatitis B Patients with Liver Fibrosis. Evidence-based Complementary and Alternative Medicine. 2019. 1–13. 7 indexed citations
6.
7.
8.
Sun, Yang, Yi-Yu Lu, Eric Lau, et al.. (2017). Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis. Anticancer Research. 37(11). 6141–6151. 57 indexed citations
9.
Lu, Yi-Yu, Yu Zhao, Yanan Song, et al.. (2015). Serum cytokine profiling analysis for zheng differentiation in chronic hepatitis B. Chinese Medicine. 10(1). 24–24. 13 indexed citations
10.
Lu, Yi-Yu, Qilong Chen, Yan Guan, et al.. (2014). Transcriptional profiling and co-expression network analysis identifies potential biomarkers to differentiate chronic hepatitis B and the caused cirrhosis. Molecular BioSystems. 10(5). 1117–1125. 15 indexed citations
11.
Li, Qing‐Ya, et al.. (2013). Network Pharmacology: A New Approach for Chinese Herbal Medicine Research. Evidence-based Complementary and Alternative Medicine. 2013. 1–9. 240 indexed citations
12.
Su, Shi-Bing. (2012). Bio-chip technology and its application development on the traditional Chinese medicine research. Zhonghua zhongyiyao zazhi.
13.
Lu, Yi-yu, et al.. (2010). Research on the assessment of clinical therapeutic effectiveness of TCM based on similarity match measure.. Zhongguo zhongyiyao xinxi zazhi. 17(11). 6–9. 2 indexed citations
14.
Su, Shi-Bing. (2010). Experimental study on Baicalein inhibiting the invasion and migration of human breast cancer cells. Zhongguo yaolixue tongbao. 1 indexed citations
15.
Su, Shi-Bing. (2007). Review on experimental research of Chinese herbal medicine intervenion for breast cancer. 1 indexed citations
16.
Su, Shi-Bing, Yoshiharu Motoo, Juan Iovanna, et al.. (2001). Expression of p8 in human pancreatic cancer.. Clinical Cancer Research. 7(2). 309–13. 68 indexed citations
17.
Su, Shi-Bing, Yoshiharu Motoo, Juan Iovanna, et al.. (2001). Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer.. Clinical Cancer Research. 7(5). 1320–4. 74 indexed citations
18.
Su, Shi-Bing, et al.. (1999). [An experimental study of metacresol burn].. PubMed. 15(4). 305–8. 1 indexed citations
19.
Su, Shi-Bing, et al.. (1999). Expression of Pancreatitis-Associated Protein (PAP) in Rat Spontaneous Chronic Pancreatitis. Pancreas. 19(3). 239–247. 29 indexed citations
20.
Su, Shi-Bing. (1956). COLORIMETRIC DETERMINATION OF MENADIONE SODIUM BISULFITE IN TABLETS. Yaoxue xuebao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojiaoyang Li Breakdown of academic impact, for papers by Xiaoying Wang Breakdown of academic impact, for papers by Ji‐Xing Nan Breakdown of academic impact, for papers by Shizhang Wei Breakdown of academic impact, for papers by Feifei Guo Breakdown of academic impact, for papers by Guang Liang Breakdown of academic impact, for papers by Hui‐Ling Chiou Breakdown of academic impact, for papers by Chenghai Liu Breakdown of academic impact, for papers by Ming Niu Breakdown of academic impact, for papers by Runping Liu
Rankless by CCL
2026